Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Letter to the Editor: Biases in estimation of overall survival in patients who underwent repeat resection of glioblastoma in: Journal of Neurosurgery Volume 125 Issue 2 (2016) Journals
Hazard Ratio: Interpretation & Definition - Statistics By Jim
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Value-Based Calculators in Cancer: Current State and Challenges | JCO Oncology Practice
Measures of Cancer Survival
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Survival
Kaplan–Meier estimator - Wikipedia
Cumulative incidence of overall survival calculated using Kaplan-Meier... | Download Scientific Diagram
xmlinkhub
Hazard ratio - Wikipedia
Sample size calculation: Survival analysis (logrank test)
Cancers | Free Full-Text | Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 Dichloride
10-year Kaplan–Meier overall survival by stage. These data were used to... | Download Scientific Diagram
Kaplan-Meier survival curve of overall survival. The calculation... | Download Scientific Diagram
Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text
Survival Analysis Basics - Easy Guides - Wiki - STHDA
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer | NEJM
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
